SCICALI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 2.812
AS - Asia 1.614
EU - Europa 1.551
SA - Sud America 336
AF - Africa 292
OC - Oceania 1
Totale 6.606
Nazione #
US - Stati Uniti d'America 2.752
IT - Italia 944
SG - Singapore 698
CN - Cina 530
BR - Brasile 307
IE - Irlanda 238
CI - Costa d'Avorio 181
KR - Corea 128
IN - India 101
SN - Senegal 77
VN - Vietnam 65
DE - Germania 63
UA - Ucraina 52
CA - Canada 49
GB - Regno Unito 46
RU - Federazione Russa 46
SE - Svezia 36
FI - Finlandia 35
NL - Olanda 20
TR - Turchia 19
FR - Francia 17
HK - Hong Kong 15
NG - Nigeria 13
PL - Polonia 13
UZ - Uzbekistan 11
AT - Austria 9
AR - Argentina 8
MA - Marocco 8
PK - Pakistan 7
ES - Italia 6
IQ - Iraq 6
MX - Messico 6
BD - Bangladesh 5
CH - Svizzera 5
JP - Giappone 5
ZA - Sudafrica 5
BG - Bulgaria 4
CL - Cile 4
VE - Venezuela 4
BE - Belgio 3
CO - Colombia 3
EC - Ecuador 3
KE - Kenya 3
LT - Lituania 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GR - Grecia 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 6.606
Città #
Santa Clara 703
Singapore 455
Chandler 434
Chicago 273
Hefei 246
Dublin 235
Catania 183
Abidjan 181
Civitanova Marche 152
Seoul 128
Boardman 122
Ashburn 118
Rome 85
Kochi 81
Dakar 77
Beijing 76
Cambridge 66
Dallas 65
Lawrence 60
Andover 58
Jacksonville 56
Dong Ket 51
Los Angeles 48
Wilmington 42
Des Moines 34
Milan 29
Nanjing 28
Toronto 27
Bremen 24
Palermo 21
The Dalles 21
Carrara 19
Padova 19
São Paulo 19
Lappeenranta 17
Houston 15
New York 15
Belo Horizonte 14
Messina 14
Munich 14
Saint Petersburg 14
Columbus 13
Hong Kong 13
San Francisco 13
Seattle 13
Abuja 12
Menlo Park 12
Shenyang 11
Turku 11
Council Bluffs 10
Gravina di Catania 10
Hebei 10
Warsaw 10
Bari 9
Brooklyn 9
San Mateo 9
Washington 9
Hanoi 8
Istanbul 8
Ottawa 8
Reggio Emilia 8
Rio de Janeiro 8
Brasília 7
Helsinki 7
London 7
Montreal 7
Pollenza 7
Enna 6
Leawood 6
Naples 6
Salvador 6
Tashkent 6
Aci Sant'Antonio 5
Amsterdam 5
Boston 5
Chennai 5
Civitavecchia 5
Curitiba 5
Guangzhou 5
Jiaxing 5
Nanchang 5
Ragusa 5
Sankt Augustin 5
Shanghai 5
Tianjin 5
Tokyo 5
Woodbridge 5
Ankara 4
Belpasso 4
Boydton 4
Cagliari 4
Genoa 4
Giarre 4
Manchester 4
Misilmeri 4
Mumbai 4
Nuremberg 4
Redmond 4
Santiago 4
Vallefiorita 4
Totale 4.745
Nome #
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 175
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 116
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 116
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 114
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 111
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 110
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 103
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 102
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 98
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 96
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 95
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 94
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 93
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 90
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 89
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 86
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 86
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 85
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 85
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 83
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 82
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 82
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 82
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 81
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 80
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 79
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 78
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 78
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 78
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 77
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 76
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 75
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 73
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 73
Clinical and molecular biomarkers for diagnosis and staging of nafld 73
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 73
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 71
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 71
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 70
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 70
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 69
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 68
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 67
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 66
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 65
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 64
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 62
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 62
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 62
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 62
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 62
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 61
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 61
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 60
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature. 60
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 60
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 59
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 58
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 57
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 57
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 56
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 55
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 55
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 54
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 54
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 53
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 53
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 53
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies 52
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 52
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 52
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 51
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 51
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 51
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 50
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? 50
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 50
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 50
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 49
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 49
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 49
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 48
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 47
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 46
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 46
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 46
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 45
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues 44
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 44
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 44
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 42
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 41
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 40
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 38
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 38
Advancements in risk stratification and management strategies in primary cardiovascular prevention 38
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 38
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 37
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 36
Associations between Host Genetic Variants and Subgingival Microbiota in Patients with the Metabolic Syndrome 36
Totale 6.674
Categoria #
all - tutte 28.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021245 0 0 12 5 47 15 19 3 14 37 31 62
2021/2022534 37 57 1 21 90 38 70 41 27 7 21 124
2022/20231.115 69 95 33 137 105 170 5 192 214 14 42 39
2023/2024798 37 118 50 27 45 165 52 89 10 27 104 74
2024/20252.943 70 400 138 261 554 390 134 77 145 226 337 211
2025/2026876 384 447 45 0 0 0 0 0 0 0 0 0
Totale 6.826